You can say what you like about how the funds are to be used. But the simple fact is they've run out of cash as somebody else has pointed out. Thats why the share price is suffering.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025